Abstract: Compositions and methods for the treatment of viral infections include conjugates containing inhibitors of viral neuraminidase (e.g., zanamivir, peramivir, or analogs thereof) linked to an Fc monomer, an Fc domain, and Fc-binding peptide, an albumin protein, or albumin-binding peptide. In particular, conjugates can be used in the treatment of viral infections (e.g., influenza viral infections).

Abstract: A sensing device for a hydrant in a fluid distribution system configured to transport a fluid can include a housing defining a portion of an operating stem of the hydrant; a vein connected to the housing, the vein defining a channel; and a sensor received at least partly and within the channel of the vein and configured to measure at least two properties of the fluid.

Abstract: Compositions and methods for the treatment of viral infections include conjugates containing inhibitors of viral neuraminidase (e.g., zanamivir, peramivir, or analogs thereof) linked to an Fc monomer, an Fc domain, and Fc-binding peptide, an albumin protein, or albumin-binding peptide. In particular, conjugates can be used in the treatment of viral infections (e.g., influenza viral infections).

Abstract: A gaming device may present a game object-based wagering game or promotional event. Game objects, including play and prize objects, may be associated with one or more play surfaces, with an object to move them to a collection area. Collected objects may result in the award of prizes. The gaming device may also be configured to present a wagering game, where play of the object-based game may be triggered from play of the wagering game.

Abstract: A gaming machine is provided. The gaming machine includes a monetary funds accepting mechanism for accepting monetary funds in creating a player credit balance, at least one display device, at least one player input device comprising a joystick, a memory device, a controller, and machine-readable code. The joystick includes a handle having a transparent or semi-transparent portion, and at least one light-emitting or generating element associated with the handle. The light-emitting or generating element is configured to emit light through the transparent or semi-transparent portion.

Abstract: Compositions and methods for the treatment of viral infections include conjugates containing inhibitors of viral neuraminidase (e.g., zanamivir, peramivir, or analogs thereof) linked to an Fc monomer, an Fc domain, and Fc-binding peptide, an albumin protein, or albumin-binding peptide. In particular, conjugates can be used in the treatment of viral infections (e.g., influenza viral infections).

Abstract: Compositions and methods for the treatment of viral infections include conjugates containing inhibitors of viral neuraminidase (e.g., zanamivir, peramivir, or analogs thereof) linked to an Fc monomer, an Fc domain, and Fc-binding peptide, an albumin protein, or albumin-binding peptide. In particular, conjugates can be used in the treatment of viral infections (e.g., influenza viral infections).

Abstract: Compositions and methods for the treatment of viral infections include conjugates containing inhibitors of viral neuraminidase (e.g., zanamivir, peramivir, or analogs thereof) linked to an Fc monomer, an Fc domain, and Fc-binding peptide, an albumin protein, or albumin-binding peptide. In particular, conjugates can be used in the treatment of viral infections (e.g., influenza viral infections).

Abstract: A system for processing medical prescriptions is disclosed. The system comprises computer hardware in communication with a customer, a prescriber, and a plurality of pharmacies. The computer hardware includes a processor and a storage medium including instructions for execution by the processor to receive insurance information from the customer and receive a medical prescription and prescription-related rules from the prescriber. The processors obtain a customer cost associated with fulfilling the medical prescription at each pharmacy based on the insurance information and communicate the customer costs to the customer. The customer provides pharmacy selection input (e.g., one or more preferred pharmacies) and the processors transmit the medical prescription to a selected pharmacy for fulfillment based on the prescription-related rules (e.g., a list of approved pharmacies).

Abstract: A double walled illuminated vessel for displaying indicia comprising an outer sleeve, an inner liner, a lens, a transparent or translucent connection ring, a base and an illumination module adapted to be inserted into the base whereby the base and connection ring are connected to each other creating a base illumination unit. Light from the illumination module passes through the hollow space between the outer sleeve and the inner liner such that the lens bearing indicia is illuminated thus prominently displaying any desired graphic, logo, design, trademark, symbol, letter, number or any other indicia. The connection ring transmits and diffuses light through the inner liner and upper rim as well as the sidewall of the connection ring. The base illumination unit is removable from the outer sleeve and can be used as an independent light source by a user. Additionally, the illumination module is rechargeable in one embodiment and can provide an adequate charge to a mobile device.

Abstract: The invention relates to a method for production of wafers of nitrides of element (13) (5a, 5b, 5c, 5d) from a self-supported crystal of nitride of element (13), extending longitudinally along a main axis orthogonal to a growth face of the crystal and passing through the centre of said growth face, the crystal (10) having a truncation angle with a non-zero value, remarkable in that the method comprises a phase of cutting the self-supported crystal along the transverse cutting planes of the crystal in order to obtain wafers of nitride of element (13), each wafer including a front face having a non-zero truncation angle in the vicinity of the centre of the front face.

Abstract: The invention relates to a method for production of wafers of nitrides of element (13) (5a, 5b, 5c, 5d) from a self-supported crystal of nitride of element (13), extending longitudinally along a main axis orthogonal to a growth face of the crystal and passing through the centre of said growth face, the crystal (10) having a truncation angle with a non-zero value, remarkable in that the method comprises a phase of cutting the self-supported crystal along the transverse cutting planes of the crystal in order to obtain wafers of nitride of element (13), each wafer including a front face having a non-zero truncation angle in the vicinity of the centre of the front face.

Abstract: Isolated proteins and immunogenic fragments thereof, for use in the treatment and prevention of a Group A Streptococcus infection are provided. In particular, the invention provides pharmaceutical compositions and methods of prophylactic and/or therapeutic treatment of a Group A Streptococcus infection.

Abstract: Isolated proteins and immunogenic fragments thereof, for use in the treatment and prevention of a Group A Streptococcus infection are provided. In particular, the invention provides pharmaceutical compositions and methods of prophylactic and/or therapeutic treatment of a Group A Streptococcus infection.

Abstract: Methods for processing overhead imagery of a vessel include the step of determining an initial classification and classification probability based on the vessel length and length-to-width ratio. Next, mutually exclusive deck features can be extracted from the image. For several embodiments, the extracted deck features that can be spherical tanks, hatches and containers that are stored on deck. The initial classification probability is then weighted using the results of the deck feature extraction step to yield a posterior classification probability for the ship image. If the posterior classification probability is above a predetermined value, the image is assigned a posterior classification. If the posterior probability is below the predetermined value, the vessel image is classified as unknown, and the gross tonnage of the vessel is calculated using the length and width of the vessel.

Abstract: Isolated proteins and immunogenic fragments thereof, for use in the treatment and prevention of a Group A Streptococcus infection are provided. In particular, the invention provides pharmaceutical compositions and methods of prophylactic and/or therapeutic treatment of a Group A Streptococcus infection.

Abstract: Provided is a printing device comprising a hot roller having an inside surface and an outside surface. A heating element is present within the hot roller. The inside surface has a first region, wherein the first region is coated with a first type of material. The inside surface has a second region, wherein the second region is coated with the first type of material, and wherein second region is of a different dimension than the first region. The inside surface has a third region, wherein the third region is coated with a second type of material.

Abstract: According to one embodiment of the invention, a network system for carrying control data between a controller and a device to be controlled is provided. The network system comprises a bus system operable to carry data between the controller and the device according to an IEEE 1394 standard. The IEEE 1394 standard defines a start up operation that includes one or more sequences. The bus system is also operable to perform a modified start up operation that excludes at least one of the sequences of the start up operation defined by the IEEE 1394 standard.